Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Marc Bonaca

Concepts (504)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
90
2025
456
31.490
Why?
Myocardial Infarction
88
2024
1015
16.190
Why?
Platelet Aggregation Inhibitors
76
2025
440
14.890
Why?
Rivaroxaban
27
2024
253
9.530
Why?
Aspirin
32
2024
376
7.770
Why?
Stroke
41
2024
1063
7.050
Why?
Acute Coronary Syndrome
34
2024
267
6.560
Why?
Lactones
24
2022
58
6.320
Why?
Purinergic P2Y Receptor Antagonists
27
2025
66
6.160
Why?
Lower Extremity
26
2025
402
5.990
Why?
Thrombosis
21
2024
324
5.930
Why?
Secondary Prevention
42
2024
219
5.740
Why?
Adenosine
20
2023
211
5.660
Why?
Pyridines
27
2022
475
5.660
Why?
Fibrinolytic Agents
16
2024
246
5.410
Why?
Vascular Surgical Procedures
14
2024
293
5.180
Why?
Atherosclerosis
22
2025
403
5.070
Why?
Factor Xa Inhibitors
16
2024
169
5.060
Why?
Ischemia
26
2024
395
4.850
Why?
Endovascular Procedures
12
2024
302
4.490
Why?
Hemorrhage
44
2025
645
4.390
Why?
Coronary Artery Disease
17
2025
678
4.000
Why?
Treatment Outcome
96
2025
10152
3.710
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
14
2024
413
3.680
Why?
Diabetes Mellitus, Type 2
25
2025
2430
3.520
Why?
Cardiovascular Diseases
29
2024
1999
3.100
Why?
Venous Thromboembolism
13
2025
271
3.070
Why?
Troponin I
10
2022
75
3.010
Why?
Humans
267
2025
128418
2.900
Why?
Drug Therapy, Combination
28
2025
1009
2.900
Why?
Aged
127
2025
21953
2.880
Why?
Anticholesteremic Agents
7
2024
146
2.770
Why?
Risk Factors
76
2025
9704
2.690
Why?
Aortic Diseases
5
2022
114
2.660
Why?
Brain Ischemia
8
2022
305
2.610
Why?
Double-Blind Method
45
2025
1848
2.440
Why?
Anticoagulants
18
2025
613
2.390
Why?
Thrombolytic Therapy
8
2021
130
2.370
Why?
Middle Aged
113
2025
30889
2.320
Why?
Drug-Eluting Stents
4
2023
64
2.120
Why?
Risk Assessment
33
2025
3232
2.030
Why?
Heart Failure
17
2024
2145
2.000
Why?
Male
141
2025
62858
2.000
Why?
Diabetes Mellitus
11
2023
1000
1.970
Why?
Randomized Controlled Trials as Topic
23
2025
1356
1.940
Why?
Renal Insufficiency, Chronic
5
2022
561
1.920
Why?
Dyslipidemias
4
2021
176
1.920
Why?
Cholesterol, LDL
7
2024
360
1.900
Why?
Female
139
2025
68154
1.890
Why?
Atrial Fibrillation
6
2025
377
1.820
Why?
Receptor, PAR-1
10
2019
21
1.780
Why?
Walking
7
2025
494
1.770
Why?
Intermittent Claudication
7
2025
118
1.670
Why?
Glucosides
8
2020
38
1.640
Why?
Benzhydryl Compounds
8
2020
66
1.600
Why?
ST Elevation Myocardial Infarction
6
2025
52
1.580
Why?
Ventricular Function, Left
4
2024
524
1.560
Why?
Hospitalization
12
2025
2057
1.470
Why?
Blood Coagulation Disorders
2
2023
162
1.400
Why?
Percutaneous Coronary Intervention
8
2025
466
1.330
Why?
Embolism
2
2022
41
1.320
Why?
Stroke Volume
6
2024
586
1.310
Why?
Time Factors
35
2025
6482
1.310
Why?
Troponin T
6
2022
57
1.270
Why?
Hypolipidemic Agents
2
2021
93
1.260
Why?
Extremities
6
2021
128
1.210
Why?
Coronary Thrombosis
4
2018
23
1.200
Why?
Follow-Up Studies
27
2022
4892
1.190
Why?
Hypoglycemic Agents
11
2025
1212
1.090
Why?
Postoperative Complications
3
2024
2485
1.080
Why?
Piperazines
8
2014
336
1.080
Why?
Glucagon-Like Peptides
2
2025
49
1.080
Why?
Receptors, Thrombin
5
2015
12
1.070
Why?
Biomarkers
29
2025
3880
1.050
Why?
Vascular Diseases
4
2023
232
1.020
Why?
Phosphatidylcholine-Sterol O-Acyltransferase
2
2022
5
1.010
Why?
Kaplan-Meier Estimate
16
2024
853
1.010
Why?
Electrocardiography
8
2018
604
1.000
Why?
Sterol O-Acyltransferase
2
2022
5
1.000
Why?
Cardiovascular Agents
4
2022
152
0.980
Why?
Myocardial Ischemia
6
2021
248
0.960
Why?
Hypercholesterolemia
2
2024
101
0.950
Why?
Mobile Applications
2
2024
159
0.940
Why?
Incretins
1
2025
18
0.940
Why?
Kidney Diseases
5
2020
367
0.920
Why?
Prasugrel Hydrochloride
6
2024
22
0.920
Why?
Incidence
16
2025
2616
0.910
Why?
Limb Salvage
6
2024
58
0.900
Why?
International Classification of Diseases
1
2024
123
0.880
Why?
Chest Pain
4
2017
89
0.870
Why?
Fibrin Fibrinogen Degradation Products
2
2023
78
0.860
Why?
Cardiology
3
2022
260
0.860
Why?
Acute Disease
8
2021
964
0.850
Why?
Acetanilides
6
2014
11
0.840
Why?
Recurrence
21
2024
996
0.830
Why?
Patient Selection
3
2022
663
0.820
Why?
Anterior Wall Myocardial Infarction
1
2022
2
0.810
Why?
Antifibrinolytic Agents
1
2023
47
0.810
Why?
Prospective Studies
22
2025
7036
0.810
Why?
Outpatients
3
2024
366
0.780
Why?
Disease Management
3
2025
587
0.770
Why?
Medicare
9
2024
715
0.750
Why?
Paclitaxel
2
2021
214
0.740
Why?
Serine Proteinase Inhibitors
2
2020
43
0.740
Why?
Databases, Factual
5
2024
1269
0.730
Why?
Cerebrovascular Disorders
2
2018
89
0.720
Why?
Proprotein Convertase 9
6
2021
68
0.720
Why?
Beneficence
1
2021
17
0.720
Why?
Dyspnea
2
2020
238
0.710
Why?
Platelet Aggregation
5
2023
91
0.710
Why?
Myocarditis
2
2019
98
0.710
Why?
Research Subjects
1
2021
42
0.700
Why?
Personal Autonomy
1
2021
48
0.690
Why?
Diabetes Complications
2
2021
223
0.680
Why?
Prognosis
15
2024
3772
0.680
Why?
Renal Insufficiency
2
2021
148
0.680
Why?
Sex Characteristics
2
2023
721
0.670
Why?
Cholesterol
4
2022
406
0.670
Why?
Caffeine
1
2020
61
0.670
Why?
Beverages
1
2020
67
0.670
Why?
Lipoproteins, HDL
4
2024
85
0.660
Why?
Informed Consent
1
2021
168
0.650
Why?
Leg
1
2021
240
0.640
Why?
Patient Care Team
1
2024
605
0.630
Why?
United States
22
2025
13830
0.620
Why?
Aortic Aneurysm, Thoracic
1
2020
127
0.620
Why?
Ezetimibe
1
2018
26
0.620
Why?
Syndrome
5
2023
335
0.620
Why?
Quality of Life
4
2025
2680
0.610
Why?
Stents
4
2021
503
0.610
Why?
Consensus
2
2022
613
0.600
Why?
Natriuretic Peptide, Brain
5
2023
99
0.590
Why?
Aged, 80 and over
15
2024
7033
0.590
Why?
Ovarian Neoplasms
1
2023
488
0.580
Why?
Blood Platelets
5
2023
376
0.580
Why?
Drug Administration Schedule
10
2024
751
0.580
Why?
Diagnostic Imaging
1
2020
330
0.570
Why?
Dose-Response Relationship, Drug
10
2021
1936
0.570
Why?
Hypertension
3
2025
1235
0.570
Why?
Growth Differentiation Factor 15
3
2023
39
0.550
Why?
Neoplasms
3
2023
2464
0.550
Why?
Proportional Hazards Models
11
2021
1196
0.550
Why?
Cause of Death
8
2024
393
0.540
Why?
Medical Oncology
1
2019
271
0.540
Why?
Survival Rate
6
2021
1869
0.540
Why?
Heparin
3
2023
240
0.530
Why?
Smoking Cessation
2
2024
408
0.530
Why?
Enzyme Inhibitors
5
2014
809
0.500
Why?
Death, Sudden, Cardiac
3
2018
179
0.500
Why?
Patient Readmission
1
2021
664
0.500
Why?
Ulcer
2
2021
29
0.490
Why?
Hematoma
2
2021
54
0.480
Why?
Ankle Brachial Index
5
2025
36
0.470
Why?
Blood Glucose
1
2025
2093
0.470
Why?
Non-ST Elevated Myocardial Infarction
3
2019
19
0.470
Why?
Benzazepines
3
2019
40
0.460
Why?
Apolipoprotein A-I
2
2024
28
0.450
Why?
Antibodies, Monoclonal
2
2018
1355
0.450
Why?
Glucagon-Like Peptide 1
2
2025
112
0.440
Why?
Thiophenes
2
2011
118
0.440
Why?
Diabetic Cardiomyopathies
3
2019
34
0.440
Why?
Global Health
4
2021
327
0.430
Why?
Ranolazine
7
2014
25
0.410
Why?
Venous Thrombosis
3
2025
161
0.400
Why?
Life Style
1
2015
460
0.400
Why?
Lecithins
2
2022
4
0.400
Why?
Pregnancy-Associated Plasma Protein-A
1
2012
14
0.400
Why?
Intracranial Hemorrhages
5
2018
78
0.400
Why?
MicroRNAs
3
2023
677
0.390
Why?
Cohort Studies
10
2022
5388
0.380
Why?
Tomography, X-Ray Computed
1
2021
2523
0.380
Why?
Diabetes Mellitus, Experimental
2
2023
173
0.380
Why?
Multicenter Studies as Topic
5
2021
285
0.380
Why?
Signal Processing, Computer-Assisted
1
2012
143
0.370
Why?
Enoxaparin
2
2021
59
0.360
Why?
Antibodies, Monoclonal, Humanized
4
2021
755
0.350
Why?
Thrombin
3
2021
142
0.350
Why?
Angina Pectoris
2
2009
67
0.340
Why?
Angioplasty, Balloon, Coronary
2
2009
138
0.330
Why?
Clinical Trials, Phase III as Topic
5
2021
90
0.330
Why?
Exercise Tolerance
2
2025
268
0.320
Why?
Appetite Depressants
2
2019
16
0.310
Why?
Thromboembolism
3
2024
102
0.300
Why?
Clinical Trials as Topic
4
2021
993
0.300
Why?
Retrospective Studies
9
2024
14454
0.300
Why?
Coronary Artery Bypass
3
2016
221
0.300
Why?
Exercise
2
2021
1929
0.300
Why?
Troponin
3
2020
50
0.290
Why?
Hospital Mortality
3
2021
844
0.290
Why?
Adult
21
2025
35300
0.290
Why?
Europe
3
2021
359
0.290
Why?
Risk
5
2019
853
0.290
Why?
Registries
7
2025
1877
0.280
Why?
Ticlopidine
5
2016
54
0.280
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2018
45
0.280
Why?
Factor XI
2
2024
9
0.280
Why?
American Heart Association
3
2022
298
0.280
Why?
Metabolic Syndrome
2
2021
338
0.280
Why?
Antineoplastic Agents, Immunological
2
2019
175
0.270
Why?
Combined Modality Therapy
4
2020
1204
0.270
Why?
Ventricular Function
1
2006
60
0.260
Why?
Glomerular Filtration Rate
3
2019
681
0.260
Why?
Popliteal Artery
2
2023
58
0.260
Why?
Internationality
3
2022
148
0.260
Why?
Heparin, Low-Molecular-Weight
2
2023
28
0.240
Why?
Angioplasty, Balloon
3
2023
88
0.240
Why?
Diabetic Nephropathies
2
2019
278
0.240
Why?
Obesity
4
2019
2858
0.240
Why?
Peptide Fragments
2
2023
684
0.240
Why?
Pulmonary Embolism
2
2025
202
0.240
Why?
Heterocyclic Compounds, 2-Ring
1
2024
8
0.230
Why?
Pravastatin
2
2016
26
0.230
Why?
Recovery of Function
3
2025
641
0.230
Why?
Injections, Subcutaneous
1
2025
144
0.230
Why?
Walk Test
1
2025
69
0.230
Why?
Aortic Aneurysm
2
2016
64
0.230
Why?
Immunotherapy
2
2019
587
0.230
Why?
Angiography
2
2024
192
0.230
Why?
Comorbidity
3
2020
1543
0.230
Why?
Severity of Illness Index
3
2018
2722
0.220
Why?
Cardiovascular System
2
2022
137
0.220
Why?
Pragmatic Clinical Trials as Topic
2
2021
62
0.220
Why?
Heptanoic Acids
2
2015
62
0.220
Why?
Angioplasty
1
2023
47
0.210
Why?
Age Factors
5
2024
3103
0.210
Why?
Psychiatric Rehabilitation
1
2023
3
0.210
Why?
Angina, Unstable
3
2013
77
0.210
Why?
Arteries
2
2022
262
0.210
Why?
Thromboplastin
1
2023
69
0.210
Why?
Computed Tomography Angiography
1
2024
115
0.210
Why?
Echocardiography
2
2024
623
0.210
Why?
Pyrroles
2
2015
191
0.200
Why?
Sensitivity and Specificity
4
2014
1815
0.200
Why?
Pyridones
1
2024
159
0.200
Why?
Kidney
2
2020
1302
0.200
Why?
Liraglutide
1
2022
29
0.190
Why?
Thiazoles
1
2022
115
0.190
Why?
Coronary Angiography
1
2024
306
0.190
Why?
Symporters
1
2022
54
0.190
Why?
Numbers Needed To Treat
1
2021
7
0.190
Why?
Doxorubicin
1
2023
322
0.190
Why?
Predictive Value of Tests
5
2018
1935
0.190
Why?
Inflammation
3
2023
2654
0.190
Why?
Mobility Limitation
1
2022
61
0.190
Why?
Warfarin
1
2022
146
0.190
Why?
Frailty
1
2024
153
0.190
Why?
Early Termination of Clinical Trials
1
2021
15
0.180
Why?
Aortic Valve Stenosis
1
2024
215
0.180
Why?
Antihypertensive Agents
1
2025
485
0.180
Why?
Myocardial Revascularization
4
2021
69
0.180
Why?
Precision Medicine
1
2025
384
0.180
Why?
Pyrimidines
1
2024
445
0.180
Why?
Blood Vessel Prosthesis Implantation
1
2023
198
0.180
Why?
Tissue Plasminogen Activator
1
2022
219
0.180
Why?
Placebos
1
2021
201
0.170
Why?
Drug Therapy
1
2021
77
0.170
Why?
Heart Diseases
2
2016
345
0.170
Why?
Exercise Therapy
3
2022
413
0.170
Why?
Antineoplastic Agents, Phytogenic
1
2021
185
0.170
Why?
Methylamines
1
2020
27
0.170
Why?
Blood Coagulation
1
2021
227
0.170
Why?
Survival Analysis
2
2014
1263
0.170
Why?
Medication Adherence
1
2024
560
0.170
Why?
Carcinoma, Renal Cell
1
2022
179
0.170
Why?
Reproducibility of Results
4
2023
3020
0.160
Why?
Glucagon-Like Peptide Receptors
1
2019
1
0.160
Why?
Osteoporosis, Postmenopausal
1
2019
40
0.160
Why?
Pharmaceutical Preparations
1
2021
168
0.160
Why?
Lipoprotein(a)
1
2020
67
0.160
Why?
Patient Education as Topic
1
2024
737
0.160
Why?
Sleep Apnea Syndromes
1
2020
79
0.160
Why?
Biphenyl Compounds
1
2019
64
0.160
Why?
Heart
1
2023
635
0.160
Why?
Serotonin 5-HT2 Receptor Agonists
1
2019
6
0.160
Why?
Bone Density Conservation Agents
1
2019
71
0.160
Why?
Weight Loss
3
2019
725
0.160
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
2
2009
21
0.160
Why?
Microcirculation
1
2019
137
0.160
Why?
Hemoglobins
1
2021
336
0.160
Why?
Appetite Regulation
1
2019
26
0.160
Why?
Pharmacovigilance
1
2018
21
0.160
Why?
Cardiac Rehabilitation
1
2019
35
0.160
Why?
Adamantane
1
2018
15
0.150
Why?
Drug Approval
2
2019
86
0.150
Why?
Coronary Disease
2
2018
382
0.150
Why?
Platelet Activation
2
2017
88
0.150
Why?
Dipeptides
1
2018
48
0.150
Why?
Reoperation
1
2021
557
0.150
Why?
Polyethylene Glycols
1
2023
596
0.150
Why?
Canagliflozin
1
2018
9
0.150
Why?
Young Adult
6
2024
12312
0.150
Why?
Adverse Drug Reaction Reporting Systems
1
2018
74
0.150
Why?
Research Personnel
1
2020
156
0.150
Why?
Ischemic Attack, Transient
2
2015
60
0.150
Why?
Anti-Obesity Agents
1
2018
53
0.150
Why?
Kidney Neoplasms
1
2022
349
0.140
Why?
Calibration
1
2018
135
0.140
Why?
Peripheral Vascular Diseases
1
2018
102
0.140
Why?
Health Care Costs
1
2021
367
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2023
1559
0.140
Why?
Hyperglycemia
1
2021
326
0.140
Why?
Inpatients
1
2021
465
0.140
Why?
Healthcare Disparities
1
2023
579
0.140
Why?
Clinical Chemistry Tests
2
2015
10
0.140
Why?
Uracil
1
2017
30
0.140
Why?
Practice Guidelines as Topic
1
2025
1478
0.140
Why?
Pandemics
2
2022
1476
0.140
Why?
Overweight
2
2018
524
0.140
Why?
Morbidity
1
2018
301
0.140
Why?
Intestines
1
2020
344
0.140
Why?
Glycopeptides
2
2014
44
0.140
Why?
Biological Assay
2
2015
118
0.130
Why?
Smoking
2
2021
1460
0.130
Why?
Vascular Patency
1
2016
102
0.130
Why?
Pericarditis
1
2016
11
0.130
Why?
Aortitis
1
2016
10
0.130
Why?
Guideline Adherence
1
2020
521
0.130
Why?
Cross-Sectional Studies
2
2024
5039
0.130
Why?
Vascular Grafting
1
2016
12
0.130
Why?
Marketing
1
2016
28
0.130
Why?
Uncertainty
1
2016
114
0.130
Why?
Cyclopropanes
1
2016
88
0.130
Why?
Telemedicine
1
2024
782
0.130
Why?
Diabetic Angiopathies
1
2018
262
0.130
Why?
Algorithms
2
2020
1618
0.120
Why?
Piperidines
1
2017
190
0.120
Why?
Multimodal Imaging
1
2016
109
0.120
Why?
Down-Regulation
1
2017
631
0.120
Why?
ROC Curve
2
2014
500
0.120
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
269
0.120
Why?
Adiponectin
1
2017
234
0.120
Why?
France
3
2019
29
0.120
Why?
Simvastatin
1
2015
55
0.120
Why?
Muscle, Skeletal
1
2025
1627
0.120
Why?
Benzaldehydes
1
2014
10
0.120
Why?
Oximes
1
2014
20
0.120
Why?
International Cooperation
2
2013
171
0.120
Why?
Decision Support Techniques
1
2018
396
0.120
Why?
Mental Disorders
1
2023
1027
0.110
Why?
Sleep
1
2020
676
0.110
Why?
Emergency Service, Hospital
3
2017
1901
0.110
Why?
Child, Preschool
3
2024
10384
0.110
Why?
Genome-Wide Association Study
1
2020
1336
0.110
Why?
Adolescent
5
2024
20179
0.110
Why?
Hypoglycemia
1
2018
425
0.110
Why?
Biomedical Research
1
2020
635
0.110
Why?
Veterans
2
2022
1398
0.110
Why?
Bacteria
1
2020
808
0.110
Why?
Fatty Acid-Binding Proteins
1
2013
67
0.110
Why?
Social Media
1
2016
137
0.110
Why?
Periodicals as Topic
1
2016
204
0.110
Why?
Infusions, Intravenous
2
2024
385
0.100
Why?
Calgranulin A
1
2012
3
0.100
Why?
Calgranulin B
1
2012
7
0.100
Why?
C-Reactive Protein
2
2016
397
0.100
Why?
Blood Proteins
1
2014
239
0.100
Why?
Gastrointestinal Microbiome
1
2020
633
0.100
Why?
Internship and Residency
1
2022
1048
0.100
Why?
Pregnancy Proteins
1
2012
37
0.100
Why?
Osteoprotegerin
1
2012
25
0.100
Why?
Prevalence
4
2019
2547
0.100
Why?
Internet
1
2016
617
0.090
Why?
Neovascularization, Physiologic
2
2023
172
0.090
Why?
Models, Biological
1
2018
1691
0.090
Why?
Obesity, Abdominal
1
2011
47
0.090
Why?
Protein Precursors
2
2014
125
0.090
Why?
Femoral Artery
2
2022
170
0.090
Why?
Electronic Health Records
1
2018
974
0.090
Why?
Protein Kinase Inhibitors
1
2016
872
0.080
Why?
Receptors, Cell Surface
1
2011
371
0.080
Why?
Chi-Square Distribution
1
2010
511
0.080
Why?
Subclavian Steal Syndrome
1
2009
2
0.080
Why?
Bayes Theorem
2
2023
369
0.080
Why?
Child
3
2024
20655
0.080
Why?
Troponin C
1
2008
5
0.080
Why?
Natriuretic Peptides
1
2008
9
0.080
Why?
Multivariate Analysis
1
2012
1484
0.080
Why?
Exercise Test
2
2025
613
0.070
Why?
Platelet Function Tests
2
2018
25
0.070
Why?
Chronic Disease
2
2024
1705
0.070
Why?
Endothelial Cells
2
2023
698
0.070
Why?
Death
2
2020
121
0.070
Why?
Body Weight
2
2023
928
0.070
Why?
Emergency Medical Services
1
2012
518
0.060
Why?
Pregnancy
2
2024
6357
0.060
Why?
Body Mass Index
3
2023
2261
0.060
Why?
Heart Ventricles
1
2010
765
0.060
Why?
Phosphocreatine
1
2025
40
0.060
Why?
Cost-Benefit Analysis
2
2018
568
0.060
Why?
Thrombophilia
1
2025
66
0.060
Why?
Gangrene
1
2024
10
0.060
Why?
Positron Emission Tomography Computed Tomography
1
2025
84
0.060
Why?
Patient Discharge
1
2010
853
0.060
Why?
Coronary Stenosis
1
2024
39
0.060
Why?
Everolimus
1
2023
58
0.050
Why?
Plaque, Atherosclerotic
1
2024
54
0.050
Why?
Case-Control Studies
2
2022
3328
0.050
Why?
Absorbable Implants
1
2023
35
0.050
Why?
Inhibins
1
2023
45
0.050
Why?
Soluble Guanylyl Cyclase
1
2022
15
0.050
Why?
Magnetic Resonance Spectroscopy
1
2025
508
0.050
Why?
Necrosis
1
2023
229
0.050
Why?
Multimorbidity
1
2022
46
0.050
Why?
Kruppel-Like Transcription Factors
1
2022
66
0.050
Why?
Animals
5
2023
34479
0.050
Why?
Therapeutics
1
2022
12
0.050
Why?
Mice
3
2023
16602
0.050
Why?
Sex Factors
2
2021
1945
0.050
Why?
Adrenal Cortex Hormones
1
2025
518
0.050
Why?
Evidence-Based Medicine
2
2017
711
0.050
Why?
Disease Progression
2
2019
2602
0.050
Why?
Tissue Scaffolds
1
2023
199
0.050
Why?
Coated Materials, Biocompatible
1
2021
56
0.050
Why?
Sodium
1
2022
205
0.050
Why?
RNA, Small Interfering
1
2023
571
0.040
Why?
Observational Studies as Topic
1
2021
108
0.040
Why?
Transforming Growth Factor beta
1
2023
445
0.040
Why?
Genotyping Techniques
1
2020
72
0.040
Why?
Pregnancy Complications, Infectious
1
2024
364
0.040
Why?
Drug Labeling
1
2019
41
0.040
Why?
Infant
2
2024
8914
0.040
Why?
Immunosuppressive Agents
1
2023
680
0.040
Why?
Vascular Endothelial Growth Factor A
1
2022
500
0.040
Why?
Research Support as Topic
1
2020
111
0.040
Why?
Aorta
1
2021
404
0.040
Why?
Clinical Trials, Phase II as Topic
1
2018
71
0.040
Why?
Cardiotoxicity
1
2018
33
0.040
Why?
Osteoporotic Fractures
1
2019
57
0.040
Why?
Republic of Korea
1
2018
28
0.040
Why?
Hip Fractures
1
2019
82
0.040
Why?
Retinal Diseases
1
2019
86
0.040
Why?
Spinal Fractures
1
2019
81
0.040
Why?
Diet, Reducing
1
2019
86
0.040
Why?
NF-kappa B
1
2022
649
0.040
Why?
New Zealand
1
2018
45
0.040
Why?
Aortic Valve Insufficiency
1
2018
46
0.040
Why?
Advisory Committees
1
2020
218
0.040
Why?
Diuresis
1
2018
9
0.040
Why?
Sweden
1
2018
92
0.040
Why?
Peripheral Nervous System Diseases
1
2019
123
0.040
Why?
Angiotensin Receptor Antagonists
1
2018
89
0.040
Why?
Cerebral Infarction
1
2018
41
0.040
Why?
Remission Induction
1
2018
268
0.040
Why?
Machine Learning
1
2022
445
0.040
Why?
Logistic Models
1
2022
1974
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2018
199
0.040
Why?
Receptors, Purinergic P2Y12
1
2017
6
0.030
Why?
Antiviral Agents
1
2023
703
0.030
Why?
Disease Susceptibility
1
2019
331
0.030
Why?
England
1
2017
73
0.030
Why?
Up-Regulation
1
2020
825
0.030
Why?
Risk Reduction Behavior
1
2019
209
0.030
Why?
Florida
1
2017
93
0.030
Why?
Primary Prevention
1
2018
185
0.030
Why?
Insulin
2
2018
2315
0.030
Why?
Glucose
1
2022
982
0.030
Why?
Longitudinal Studies
1
2024
2710
0.030
Why?
Drug Monitoring
1
2018
186
0.030
Why?
Intensive Care Units
1
2021
717
0.030
Why?
Delivery of Health Care
1
2023
895
0.030
Why?
Marfan Syndrome
1
2016
40
0.030
Why?
Adrenergic beta-Antagonists
1
2018
318
0.030
Why?
Health Promotion
1
2022
716
0.030
Why?
Microfilament Proteins
1
2017
125
0.030
Why?
Cell Adhesion Molecules
1
2017
172
0.030
Why?
Bone Density
1
2019
474
0.030
Why?
Curriculum
1
2022
917
0.030
Why?
Genetic Predisposition to Disease
1
2024
2264
0.030
Why?
Prediabetic State
1
2018
245
0.030
Why?
Treatment Failure
1
2016
339
0.030
Why?
Clinical Competence
1
2022
1013
0.030
Why?
Long-Term Care
1
2015
89
0.030
Why?
Mortality
1
2017
307
0.030
Why?
Phosphoproteins
1
2017
327
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2017
815
0.030
Why?
Vaccination
1
2023
1346
0.030
Why?
Publishing
1
2016
140
0.030
Why?
Transcription Factors
1
2022
1628
0.030
Why?
Odds Ratio
1
2017
1023
0.030
Why?
Metformin
1
2018
312
0.030
Why?
Sodium Channel Blockers
1
2014
23
0.030
Why?
Atrial Natriuretic Factor
1
2014
56
0.030
Why?
Fractures, Bone
1
2019
418
0.030
Why?
Fatty Acid Binding Protein 3
1
2013
5
0.030
Why?
United States Food and Drug Administration
1
2015
199
0.030
Why?
Limit of Detection
1
2013
55
0.030
Why?
Massachusetts
1
2014
158
0.030
Why?
Aortic Valve
1
2016
345
0.030
Why?
Placenta Growth Factor
1
2012
24
0.030
Why?
Norway
1
2012
42
0.020
Why?
Retreatment
1
2012
69
0.020
Why?
Creatinine
1
2014
475
0.020
Why?
Interleukin-1 Receptor-Like 1 Protein
1
2011
26
0.020
Why?
Blood Pressure
1
2019
1728
0.020
Why?
Waist Circumference
1
2011
138
0.020
Why?
Anthropometry
1
2011
204
0.020
Why?
Infant, Newborn
1
2022
5687
0.020
Why?
Signal Transduction
1
2023
4826
0.020
Why?
Creatine Kinase, MB Form
1
2009
4
0.020
Why?
Atherectomy
1
2008
36
0.020
Why?
Hypertension, Pulmonary
1
2018
1745
0.020
Why?
Hemodynamics
1
2011
1081
0.020
Why?
Preoperative Care
1
2008
338
0.020
Why?
Research Design
1
2009
1036
0.010
Why?
Bonaca's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)